An ultrasound joint venture between Shanghai Medical ElectronicsInstrument Factory (SMEIF) and Ausonics of Sidney was revitalizedlate last year when the Chinese government granted approval forlocal assembly and sales. The venture was almost aborted two
An ultrasound joint venture between Shanghai Medical ElectronicsInstrument Factory (SMEIF) and Ausonics of Sidney was revitalizedlate last year when the Chinese government granted approval forlocal assembly and sales.
The venture was almost aborted two years ago by political tensionsand pressure from Chinese ultrasound vendors, said Kerrie Tarrant,Ausonics international marketing manager.
SMEIF staff is being trained in Shanghai and Australia forassembly of the Ausonics MI2000 scanner and probes in Shanghai,she said.
The two companies have skipped the planned first stage of cooperation,which called for importing complete scanners and providing clinicaltraining in China. Instead, they are initiating local assembly,technology transfer and marketing of systems. This process willcontinue through 1991, Tarrant said.
The Australian government is providing low-interest exportfinancing to the Chinese, which has helped Ausonics bypass limitationson foreign exchange availability. All of the ultrasound systemswill be sold in China, initially for women's health/family planningpurposes, Tarrant said.
The next stage of the venture should involve a broader rangeof clinical applications, both in terms of ultrasound technologytransfer and scanner marketing efforts, she said.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Clears Point-Of-Care Ultrasound Platform and AI Software for Neuraxial Procedures
July 17th 2025The dual FDA clearances for the Accuro 3S point-of-care ultrasound device and the SpineNav-AI machine learning-based software may enhance precision and safety with ultrasound-guided neuraxial procedures.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.